Domestic formulation business for drug makers see recovery in Q2 as GST impact eases
newsdepo.com
Domestic sales of top-10 drug makers listed on stock exchanges in Q2 grew on sequential basis by 30 percent, while the growth was 13 percent on year-on-year basis indicating a strong recovery.Domestic formulation business for drug makers see recovery in Q2 as GST impact eases
Domestic sales of top-10 drug makers listed on stock exchanges in Q2 grew on sequential basis by 30 percent, while the growth was 13 percent on year-on-year basis indicating a strong recovery. Read more